CVPath Leadership address CRT20 Conference
February 26th, 2020February 26, 2020 Dr. Virmani, President, and Dr. Finn, Medical Director, of CVPath Institute recently presented at CRT20 held February…
Read more
CVPath Yearly Summary 2019-2020 – Dr. Aloke Finn, Medical Director
January 6th, 2020Dear CVPath Friends and Colleagues, On behalf of everyone here at CVPath, it is my pleasure to wish you, your…
Read moreDr. Virmani Highly Cited Researcher
November 26th, 2019CVPath Institute’s Dr. Virmani Highly Cited Researcher According to 2019 Web of Science Group List London, UK, and Philadelphia, US…
Read moreDr. Finn Speaks at VIVA 2019 & VEINS
November 11th, 2019Dr. Aloke Finn traveled to Las Vegas for the VIVA 2019 & VEINS conference, November 5-7 where he was a…
Read moreVirmani Speaks at Advances in Cardiovascular Medicine Conference
October 31st, 2019November 2, 2019: Dr. Renu Virmani addressed participants in the WVU Heart and Vascular Institute’s second annual Advances in Cardiovascular…
Read more
CVPath Institute Receives Re-Accreditation from College of American Pathologists
October 30th, 2019CVPath Institute Inc. Laboratory Receives Re-Accreditation from College of American Pathologists October 18, 2019: The Accreditation Committee of the College…
Read moreLiang “Charles” Guo Recent Publications
October 24th, 2019Ironing-Out the Role of Hepcidin in Atherosclerosis. Abstract: Iron is an essential element for life. While it plays fundamental roles…
Read moreDipti Surve, MD Recent Publications
October 24th, 2019Multimodality Imaging Showing Pathology of Endovascular Aortic Graft for Abdominal Aortic Aneurysm. Kuntz SH1,2,3, Surve D1, Kutyna M1, Jinnouchi H1,…
Read moreFrank D. Kolodgie, Phd Recent Publications
October 24th, 2019Drug-eluting coronary stents: insights from preclinical and pathology studies. Abstract Implantation of drug-eluting stents (DES) is the dominant treatment strategy…
Read moreMaria E. Romero, MD FCAP Recent Publications
October 24th, 2019Drug-eluting coronary stents: insights from preclinical and pathology studies. Abstract Implantation of drug-eluting stents (DES) is the dominant treatment strategy…
Read more